F3 and breast cancer: In a large prospective cohort study (n = 324) of breast cancer patients, increased expression of markers of coagulation (Tissue Factor, thrombin and their respective receptors PAR2 and PAR1) are localized to fibroblasts, increased in aggressive breast cancer subtypes, and correlate with reduced overall survival.